Miha Kline has been with Eli Lilly for the past 15 years, becoming Country Manager Czech Republic and Slovakia four years ago. Kline shares his milestones with the affiliate successfully entering new therapeutic areas and reaching 1bn CZK in sales. Kline also discusses the challenging market access conditions and the company’s efforts, together with industry peers, to shorten timelines. Despite this challenge, Kline sees the Czech Republic as a transparent market with significant growth potential and focuses on developing a competent and efficient team to capture opportunities.
I think the country could benefit greatly from streamlining and shortening processes in order to foster a business-friendly environment
